Tezepelumab CAS 1572943-04-4

/in , , /by

Identification

CAS Number

1572943-04-4

Name

Tezepelumab

Properties

Safety Data

Symbol

MSDS Download

Specifications and Other Information of Our

Known Application

Tezepelumab CAS 1572943-04-4 as add-on maintenance therapy for the treatment of severe asthma in children 12 years of age and older and in adults. This is a monoclonal antibody therapy targeting anti-thymic stromal lymphopoietin (TSLP). TSLP is an epithelial cytokine that sits at the top of multiple inflammatory cascades, initiating allergic, eosinophilic, and other types of exaggerated immune responses associated with severe asthma-related airway inflammation.

General View of Documents

This product is sold exclusively through our sales company Watson International Limited, and please click the link below for details (https://www.watson-int.com/).